Literature DB >> 9239422

E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.

J L Chuang1, R P Cox, D T Chuang.   

Abstract

Maple syrup urine disease (MSUD) or branched-chain alpha-ketoaciduria is an autosomally inherited disorder in the catabolism of branched-chain amino acids leucine, isoleucine, and valine. The disease is characterized by severe ketoacidosis, mental retardation, and neurological impairments. MSUD can be classified into genetic subtypes according to the genes of the branched-chain alpha-ketoacid dehydrogenase (BCKD) complex which are affected in patients. We describe here four intronic deletions and an intronic nucleotide substitution in the E2 transacylase gene of type II MSUD, in which the E2 subunit of the BCKD complex is deficient. These new E2 mutations comprise an internal 3.2-kb deletion in intron 4 (causing a 17-bp insertion in mRNA), an internal 12-bp (ttaccttgttac) deletion in intron 4 (creating a 10-bp insertion), a 10-bp (catttctaG) deletion in intron 10/ exon 11 junction (leading to a 21-bp deletion), a 2-bp deletion in the exon 5/intron 5 junction (ATgt--> A-t) (resulting in the skipping of exon 5), and a G to A transition at nucleotide -7 of intron 9 (causing a 6-bp insertion). These intronic mutations were initially detected by secondary alterations in the mutant E2 mRNA, as a result of aberrant splicing. The 3.2-kb deletion in intron 4 was determined by the amplification of the entire intron from both a normal subject (11.2 kb) and a homozygous patient (8 kb) by long PCR, followed by subcloning and sequencing of regions flanking the deletion. Similar methods were used to identify and characterize the other intronic alterations. Our results depict heretofore undescribed splicing errors caused by the deletion of internal intronic segments, and provide an approach for detecting this class of novel and rare human mutation. The association of the thiamine-responsive phenotype with a subset of the type II MSUD patients studied is also discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9239422      PMCID: PMC508243          DOI: 10.1172/JCI119586

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions.

Authors:  R C Nichols; O Rudolphi; B Ek; R Exelbert; P H Plotz; N Raben
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

3.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

Authors:  M B Shapiro; P Senapathy
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

4.  Thiamine-responsive intermittent branched-chain ketoaciduria.

Authors:  S M Pueschel; M J Bresnan; V E Shih; H L Levy
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

5.  Purification and characterization of branched chain alpha-keto acid dehydrogenase complex of bovine kidney.

Authors:  F H Pettit; S J Yeaman; L J Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

7.  Stabilization of mammalian liver branched-chain alpha-ketoacid dehydrogenase by thiamin pyrophosphate.

Authors:  D J Danner; S K Lemmon; L J Elsas
Journal:  Arch Biochem Biophys       Date:  1980-06       Impact factor: 4.013

8.  Regulation of branched-chain alpha-ketoacid dehydrogenase complex by covalent modification.

Authors:  R A Harris; R Paxton; S M Powell; G W Goodwin; M J Kuntz; A C Han
Journal:  Adv Enzyme Regul       Date:  1986

9.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

10.  A defect in branched-chain amino acid metabolism in a patient with congenital lactic acidosis due to dihydrolipoyl dehydrogenase deficiency.

Authors:  J Taylor; B H Robinson; W G Sherwood
Journal:  Pediatr Res       Date:  1978-01       Impact factor: 3.756

View more
  7 in total

1.  Rare etiology of autosomal recessive disease in a child with noncarrier parents.

Authors:  R V Lebo; L R Shapiro; E Y Fenerci; J M Hoover; J L Chuang; D T Chuang; D F Kronn
Journal:  Am J Hum Genet       Date:  2000-07-27       Impact factor: 11.025

2.  A synchronized substrate-gating mechanism revealed by cubic-core structure of the bovine branched-chain alpha-ketoacid dehydrogenase complex.

Authors:  Masato Kato; R Max Wynn; Jacinta L Chuang; Chad A Brautigam; Myra Custorio; David T Chuang
Journal:  EMBO J       Date:  2006-11-23       Impact factor: 11.598

3.  MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

Authors:  Ailan Cheng; Lianshu Han; Yun Feng; Huimin Li; Rong Yao; Dengbin Wang; Biao Jin
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

Review 4.  Animal models of maple syrup urine disease.

Authors:  K J Skvorak
Journal:  J Inherit Metab Dis       Date:  2009-03-09       Impact factor: 4.982

5.  Maple syrup urine disease: mutation analysis in Turkish patients.

Authors:  A Dursun; M Henneke; K Ozgül; J Gartner; T Coşkun; A Tokatli; H S Kalkanoğlu; M Demirkol; U Wendel; I Ozalp
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

6.  Challenges in Diagnosing Intermediate Maple Syrup Urine Disease by Newborn Screening and Functional Validation of Genomic Results Imperative for Reproductive Family Planning.

Authors:  Mona Sajeev; Sharon Chin; Gladys Ho; Bruce Bennetts; Bindu Parayil Sankaran; Bea Gutierrez; Beena Devanapalli; Adviye Ayper Tolun; Veronica Wiley; Janice Fletcher; Maria Fuller; Shanti Balasubramaniam
Journal:  Int J Neonatal Screen       Date:  2021-05-14

7.  Case report: maple syrup urine disease with a novel DBT gene mutation.

Authors:  Wei Feng; Jinfu Jia; Heyang Guan; Qing Tian
Journal:  BMC Pediatr       Date:  2019-12-13       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.